SCHEMBL4902544

SCHEMBL4902544

COc1cccc(S(=O)(=O)Nc2cc(Cl)cnc2Oc2cccnc2C)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 12/20 0.73
CYP3A4 P08684 4/20 0.73
CYP2C9 P11712 4/20 0.73
CYP2C19 P33261 4/20 0.73
CCR4 P51679 3/20 0.73
SLC40A1 Q9NP59 2/20 0.55
GLO1 Q04760 1/20 0.55
GAA P10253 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CCR5 P51681 1/20 0.52
CYP11B1 P15538 1/20 0.48
CYP11B2 P19099 1/20 0.48
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
ALPL P05186 1/20 0.47
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4916030 0.90 CCR2 (0.76) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4907572 0.87 CCR2 (0.78) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4910636 0.87 CCR2 (0.74) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4911198 0.87 CCR2 (0.74) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4913269 0.85 CCR2 (0.82) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4902546 0.85 CCR2 (0.78) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4902474 0.85 CCR2 (1.00) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4913296 0.84 CCR2 (0.71) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4910490 0.84 CCR2 (0.71) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL4907331 0.84 CCR2 (0.71) CCR2CYP3A4CYP2C9CYP2C19CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 CCR2 1/4885CYP3A4 1414/4885CYP2C9 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.